PCSK1 and systemic inflammatory response syndrome: Additionally, necrostatin-1 (Nec-1), a RIPK1 inhibitor, effectively suppresses necroptosis, showing therapeutic promise in fatal systemic inflammatory response syndrome (SIRS) and sepsis [84].